EUVIMEDEUVIMED entdecken
Open Access

Targeting IL-1 controls refractory pityriasis rubra pilaris

Eloi Schmauch iD, Yannik Severin iD, Xianying Xing iD, Aaron Mangold iD, Curdin Conrad iD, Pål Johansen iD, J Michelle Kahlenberg iD, Mark Mellett iD, Alexander Navarini iD, Stefan Nobbe iD, Mrinal K Sarkar iD, Abhigyan Satyam iD und 11 weitere

Science Advances · 2024

DOI: 10.1126/sciadv.ado2365 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, 2024. Verfasst von Eloi Schmauch und 22 weiteren Autor:innen. Beteiligte Einrichtung: Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. Hauptthemen laut MEDLINE: Pityriasis Rubra Pilaris, Interleukin-1beta, Interleukin 1 Receptor Antagonist Protein, Keratinocytes. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pityriasis rubra pilaris (PRP) is a rare inflammatory skin disease with a poorly understood pathogenesis. Through a molecularly driven precision medicine approach and an extensive mechanistic pathway analysis in PRP skin samples, compared to psoriasis, atopic dermatitis, healed PRP, and healthy controls, we identified IL-1β as a key mediator, orchestrating an NF-κB–mediated IL-1β–CCL20 axis, including activation of CARD14 and NOD2. Treatment of three patients with the IL-1 antagonists anakinra and canakinumab resulted in rapid clinical improvement and reversal of the PRP-associated molecular signature with a 50% improvement in skin lesions after 2 to 3 weeks. This transcriptional signature was consistent with in vitro stimulation of keratinocytes with IL-1β. With the central role of IL-1β underscoring its potential as a therapeutic target, our findings propose a redefinition of PRP as an autoinflammatory keratinization disorder. Further clinical trials are needed to validate the efficacy of IL-1β antagonists in PRP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pityriasis Rubra PilarisInterleukin-1betaInterleukin 1 Receptor Antagonist ProteinKeratinocytesAntibodies, Monoclonal, HumanizedHumansMaleNF-kappa BNod2 Signaling Adaptor ProteinFemaleCARD Signaling Adaptor ProteinsSkinInterleukin-1Middle AgedGuanylate CyclaseAdultSignal TransductionMembrane Proteins

Substanzen

Interleukin-1betaInterleukin 1 Receptor Antagonist ProteinAntibodies, Monoclonal, HumanizedcanakinumabCARD14 protein, humanNF-kappa BNod2 Signaling Adaptor ProteinCARD Signaling Adaptor ProteinsInterleukin-1IL1B protein, human

Autor:innen und Institutionen

  • Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
  • Computer Science and Artificial Intelligence Laboratory, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
  • A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
  • Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, 8049 Zurich, Switzerland.
  • Departments of Internal Medicine and Dermatology, University of Michigan, Ann Arbor, MI 48109, USA.
  • Department of Dermatology, Mayo Clinic Arizona, Scottsdale, AZ 85259, USA.

ORCID-Profile: Eloi Schmauch, Yannik Severin, Xianying Xing, Aaron Mangold, Curdin Conrad, Pål Johansen, J Michelle Kahlenberg, Mark Mellett, Alexander Navarini, Stefan Nobbe, Mrinal K Sarkar, Abhigyan Satyam, Lam C Tsoi, Lars E French, Jakob Nilsson, Suvi Linna-Kuosmanen, Minna U Kaikkonen, Berend Snijder, Manolis Kellis, Johann E Gudjonsson, George C Tsokos, Emmanuel Contassot, Antonios G A Kolios

Zitieren

APA

Schmauch, E., Severin, Y., Xing, X., Mangold, A., Conrad, C., Johansen, P., Kahlenberg, J. M., Mellett, M., Navarini, A., Nobbe, S., Sarkar, M. K., Satyam, A., Tsoi, L. C., French, L. E., Nilsson, J., Linna-Kuosmanen, S., Kaikkonen, M. U., Snijder, B., Kellis, M., …, & Kolios, A. G. A. (2024). Targeting IL-1 controls refractory pityriasis rubra pilaris. Science Advances. https://doi.org/10.1126/sciadv.ado2365

Vancouver

Schmauch E, Severin Y, Xing X, Mangold A, Conrad C, Johansen P, et al. Targeting IL-1 controls refractory pityriasis rubra pilaris. Science Advances. 2024. doi:10.1126/sciadv.ado2365

BibTeX
@article{Schmauch2024,
  author = {Schmauch, Eloi and Severin, Yannik and Xing, Xianying and Mangold, Aaron and Conrad, Curdin and Johansen, Pål and Kahlenberg, J Michelle and Mellett, Mark and Navarini, Alexander and Nobbe, Stefan and Sarkar, Mrinal K and Satyam, Abhigyan and Tsoi, Lam C and French, Lars E and Nilsson, Jakob and Linna-Kuosmanen, Suvi and Kaikkonen, Minna U and Snijder, Berend and Kellis, Manolis and Gudjonsson, Johann E and Tsokos, George C and Contassot, Emmanuel and Kolios, Antonios G A},
  title = {Targeting IL-1 controls refractory pityriasis rubra pilaris},
  journal = {Science Advances},
  year = {2024},
  doi = {10.1126/sciadv.ado2365}
}
Kostenlos starten →